Zoetis Inc (ZTS)
151.94
-1.08
(-0.71%)
USD |
NYSE |
Apr 17, 16:00
151.99
+0.05
(+0.03%)
Pre-Market: 20:00
Zoetis Total Liabilities (Quarterly): 9.295B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 9.295B |
September 30, 2023 | 9.032B |
June 30, 2023 | 9.128B |
March 31, 2023 | 9.263B |
December 31, 2022 | 10.52B |
September 30, 2022 | 9.012B |
June 30, 2022 | 9.19B |
March 31, 2022 | 9.202B |
December 31, 2021 | 9.356B |
September 30, 2021 | 9.024B |
June 30, 2021 | 9.717B |
March 31, 2021 | 9.704B |
December 31, 2020 | 9.836B |
September 30, 2020 | 10.12B |
June 30, 2020 | 10.08B |
March 31, 2020 | 8.775B |
December 31, 2019 | 8.837B |
September 30, 2019 | 8.594B |
June 30, 2019 | 8.575B |
March 31, 2019 | 8.566B |
December 31, 2018 | 8.592B |
September 30, 2018 | 8.341B |
June 30, 2018 | 6.621B |
March 31, 2018 | 6.715B |
December 31, 2017 | 6.80B |
Date | Value |
---|---|
September 30, 2017 | 7.269B |
June 30, 2017 | 6.056B |
March 31, 2017 | 6.014B |
December 31, 2016 | 6.15B |
September 30, 2016 | 6.117B |
June 30, 2016 | 6.147B |
March 31, 2016 | 6.266B |
December 31, 2015 | 6.822B |
September 30, 2015 | 5.432B |
June 30, 2015 | 5.396B |
March 31, 2015 | 5.125B |
December 31, 2014 | 5.251B |
September 30, 2014 | 5.138B |
June 30, 2014 | 5.239B |
March 31, 2014 | 5.304B |
December 31, 2013 | 5.596B |
September 30, 2013 | 5.393B |
June 30, 2013 | 5.438B |
March 31, 2013 | 5.418B |
December 31, 2012 | 2.221B |
September 30, 2012 | 1.795B |
June 30, 2012 | 1.869B |
March 31, 2012 | 1.956B |
December 31, 2011 | 1.975B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
8.575B
Minimum
Jun 2019
10.52B
Maximum
Dec 2022
9.330B
Average
9.202B
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
Biogen Inc | 12.05B |
Eli Lilly and Co | 53.14B |
Pfizer Inc | 137.21B |
Abbott Laboratories | 34.39B |
Bristol-Myers Squibb Co | 65.67B |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 14.29B |
Shareholders Equity (Quarterly) | 4.997B |
Debt to Equity Ratio | 1.314 |
Current Ratio | 3.358 |
Net Debt Paydown Yield | -0.00% |